Grant: Chair: GlaxoSmithKline Partnered
Université Laval
$300,000.00
Skeletal muscle dysfunction in COPD
EF 2012-13
Résumé
The muscles from the lower limbs are commonly affected in persons suffering from a chronic respiratory disease.
This is important because this may cause exercise intolerance, quality of life and even life expectancy.
This is also important because muscles can be treated.
The purpose of this research program is to try to understand why do persons with chronic respiratory disease such as emphysema have problems with their muscles.
We hope that our research will lead to better treatment of this condition.
Programme
Chair: GlaxoSmithKline Partnered
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
268774
Name
Maltais François
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
GlaxoSmithKline (Mississauga, Ontario)
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
CIHR/GSK Partnered Chair Program
Projecttitle
Skeletal muscle dysfunction in COPD
Programtype2
Salary Programs
Orgnameinp2
Université Laval
Cihramount2
$300,000
Cihrequipment2
$0
Programname2
Chair: GlaxoSmithKline Partnered
Keyworddelim
Cachexia; Copd; Exercise; Muscle
Abstract
The muscles from the lower limbs are commonly affected in persons suffering from a chronic respiratory disease.
This is important because this may cause exercise intolerance, quality of life and even life expectancy.
This is also important because muscles can be treated.
The purpose of this research program is to try to understand why do persons with chronic respiratory disease such as emphysema have problems with their muscles.
We hope that our research will lead to better treatment of this condition.
Competitiondate
201209
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Maltais, François
Approvedterm
5 ans 0 mois
Cihrcontribution2
Patient Oriented Research~ $300,000~ $0~
